LAURA MEDFORD-DAVIS

Concepts (191)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medically Uninsured
5
2017
104
2.690
Why?
Emergency Service, Hospital
9
2020
1222
1.940
Why?
Emergency Medicine
3
2018
146
1.520
Why?
Insurance Coverage
3
2017
273
1.060
Why?
Medicaid
3
2017
312
1.040
Why?
Patient Transfer
2
2017
139
1.020
Why?
Diagnostic Errors
3
2020
524
0.860
Why?
Aftercare
3
2017
258
0.740
Why?
Health Expenditures
3
2017
218
0.730
Why?
Medical Overuse
2
2018
52
0.720
Why?
Patient Protection and Affordable Care Act
3
2017
109
0.710
Why?
Orthopedics
3
2017
75
0.660
Why?
Electronic Health Records
3
2020
987
0.630
Why?
Emergency Medical Services
3
2020
445
0.610
Why?
Deinstitutionalization
1
2017
3
0.610
Why?
Patient Discharge
3
2017
720
0.600
Why?
Emergency Services, Psychiatric
1
2017
22
0.590
Why?
Reimbursement Mechanisms
1
2017
80
0.550
Why?
Stroke Rehabilitation
1
2016
60
0.550
Why?
Health Information Exchange
1
2016
15
0.540
Why?
Wounds and Injuries
2
2017
428
0.540
Why?
Safety-net Providers
1
2016
58
0.510
Why?
Urinary Tract Infections
2
2016
332
0.490
Why?
Clinical Decision-Making
1
2018
557
0.490
Why?
Health Policy
1
2017
293
0.480
Why?
Medicare
2
2017
932
0.480
Why?
Mental Health Services
1
2017
259
0.480
Why?
Appendicitis
1
2016
176
0.470
Why?
Hypokalemia
1
2014
56
0.460
Why?
Choice Behavior
1
2016
255
0.460
Why?
Brain Ischemia
1
2016
304
0.450
Why?
Gastroenteritis
1
2016
314
0.450
Why?
Information Dissemination
1
2016
275
0.440
Why?
Potassium
1
2014
330
0.430
Why?
Program Evaluation
1
2016
624
0.430
Why?
Abdominal Pain
1
2015
376
0.420
Why?
Hyperkalemia
1
2014
81
0.420
Why?
United States
11
2024
16325
0.420
Why?
Quality of Health Care
1
2017
643
0.400
Why?
Patient Readmission
1
2016
600
0.390
Why?
Referral and Consultation
1
2017
937
0.390
Why?
Hospitalization
2
2018
2220
0.380
Why?
Diabetes Mellitus
3
2016
1114
0.380
Why?
Health Services Accessibility
1
2017
818
0.360
Why?
Carcinoma, Non-Small-Cell Lung
9
2015
5458
0.360
Why?
Mental Disorders
1
2018
915
0.350
Why?
Quality Improvement
1
2017
929
0.330
Why?
Heart Arrest
1
2014
373
0.330
Why?
Asthma
1
2016
909
0.310
Why?
Lung Neoplasms
11
2015
11638
0.290
Why?
Odds Ratio
3
2017
2302
0.290
Why?
Mass Screening
1
2016
1572
0.290
Why?
Radiation Oncology
1
2012
555
0.280
Why?
Texas
4
2018
6489
0.260
Why?
Health Care Reform
2
2017
70
0.260
Why?
Pneumonectomy
5
2013
870
0.230
Why?
Insurance, Health
2
2016
262
0.230
Why?
Cost Savings
1
2024
127
0.220
Why?
Neoplasm Recurrence, Local
8
2015
10282
0.220
Why?
HIV Infections
1
2016
2223
0.210
Why?
Humans
31
2024
270969
0.210
Why?
Male
19
2024
127769
0.200
Why?
Multivariate Analysis
4
2018
4357
0.200
Why?
Middle Aged
16
2018
89661
0.200
Why?
Lung
1
2012
3234
0.190
Why?
Forecasting
2
2015
705
0.180
Why?
Adult
13
2024
80872
0.180
Why?
Aged
15
2018
73018
0.180
Why?
Databases, Factual
2
2018
2314
0.180
Why?
Logistic Models
2
2018
3487
0.170
Why?
Female
19
2024
147624
0.170
Why?
Criminal Law
1
2017
12
0.150
Why?
Trauma Severity Indices
1
2017
91
0.150
Why?
Retrospective Studies
11
2017
39724
0.150
Why?
Refusal to Treat
1
2017
13
0.140
Why?
Fees and Charges
1
2017
17
0.140
Why?
Skilled Nursing Facilities
1
2016
15
0.140
Why?
Risk Factors
8
2016
18036
0.140
Why?
Ambulances
1
2016
24
0.140
Why?
Diagnosis-Related Groups
1
2016
25
0.140
Why?
Patient Simulation
1
2017
44
0.140
Why?
Organizational Innovation
1
2017
73
0.140
Why?
Small Cell Lung Carcinoma
2
2011
404
0.140
Why?
Appointments and Schedules
1
2017
97
0.140
Why?
Uncompensated Care
1
2016
11
0.130
Why?
Adolescent
4
2018
32464
0.130
Why?
Gallbladder Diseases
1
2015
46
0.130
Why?
Hospitals, Urban
1
2015
94
0.130
Why?
Confidentiality
1
2016
126
0.130
Why?
Medical History Taking
1
2015
172
0.120
Why?
Lost to Follow-Up
1
2014
34
0.120
Why?
Program Development
1
2016
269
0.120
Why?
Potassium Chloride
1
2014
55
0.120
Why?
Urban Population
1
2016
285
0.120
Why?
Practice Guidelines as Topic
2
2016
2487
0.120
Why?
Hypercholesterolemia
1
2016
267
0.120
Why?
Anticholesteremic Agents
1
2016
261
0.110
Why?
Antihypertensive Agents
1
2016
416
0.110
Why?
Bone Diseases
1
2014
140
0.110
Why?
Public Health
1
2016
303
0.110
Why?
Diabetes Complications
2
2013
317
0.110
Why?
Patient Safety
1
2018
678
0.100
Why?
Cognition
1
2018
999
0.100
Why?
Substance-Related Disorders
1
2017
549
0.100
Why?
Hypoglycemic Agents
1
2016
608
0.100
Why?
Guideline Adherence
1
2016
654
0.100
Why?
Longitudinal Studies
1
2017
2048
0.100
Why?
Socioeconomic Factors
1
2016
1258
0.100
Why?
Bone and Bones
1
2014
603
0.090
Why?
Carcinoma, Large Cell
1
2011
99
0.090
Why?
Biocompatible Materials
1
2011
211
0.090
Why?
Lymphatic Metastasis
4
2015
4940
0.090
Why?
Mediastinum
1
2012
276
0.090
Why?
Hospital Mortality
1
2016
1403
0.090
Why?
Young Adult
3
2018
22268
0.090
Why?
Surveys and Questionnaires
2
2024
5952
0.080
Why?
Age Factors
2
2016
5498
0.080
Why?
Collagen
1
2011
753
0.080
Why?
Stroke
1
2016
1185
0.070
Why?
Electrocardiography
1
2014
1250
0.070
Why?
Myocardium
1
2014
1343
0.070
Why?
Aged, 80 and over
7
2016
30845
0.070
Why?
Hypertension
1
2016
1576
0.070
Why?
Chemotherapy, Adjuvant
2
2012
3968
0.070
Why?
Ferric Compounds
1
2007
78
0.070
Why?
Radiotherapy, Adjuvant
1
2012
2270
0.070
Why?
Neoplasm Staging
5
2013
13883
0.070
Why?
Breast Implants
1
2011
407
0.070
Why?
Tumor Burden
1
2012
2020
0.070
Why?
Neoplasm, Residual
1
2012
1725
0.070
Why?
Cross-Sectional Studies
1
2016
4552
0.060
Why?
Patient Selection
1
2013
2111
0.060
Why?
Carcinoma, Neuroendocrine
1
2011
740
0.060
Why?
Lymph Node Excision
1
2012
2035
0.060
Why?
Lymph Nodes
1
2015
3037
0.060
Why?
Mammaplasty
1
2011
792
0.060
Why?
Antibodies
1
2007
845
0.060
Why?
Early Detection of Cancer
1
2012
1342
0.060
Why?
Randomized Controlled Trials as Topic
1
2012
2717
0.060
Why?
Risk Assessment
1
2016
7105
0.060
Why?
Radiosurgery
1
2013
1376
0.060
Why?
Image Enhancement
1
2007
569
0.050
Why?
Infant, Newborn
1
2016
8593
0.050
Why?
Time Factors
1
2016
13261
0.050
Why?
Contrast Media
1
2007
1497
0.040
Why?
Child, Preschool
1
2016
16882
0.040
Why?
Safety Management
1
2020
135
0.040
Why?
Neoadjuvant Therapy
1
2012
5156
0.040
Why?
Neoplasm Metastasis
1
2009
5250
0.040
Why?
Proportional Hazards Models
3
2011
5094
0.040
Why?
Attitude of Health Personnel
1
2024
959
0.040
Why?
Follow-Up Studies
4
2015
15255
0.040
Why?
SEER Program
2
2011
1028
0.040
Why?
Postoperative Complications
1
2011
5853
0.030
Why?
Survival Analysis
3
2011
9311
0.030
Why?
T-Lymphocytes
1
2007
3954
0.030
Why?
Matched-Pair Analysis
1
2013
98
0.030
Why?
Demography
1
2014
449
0.030
Why?
Regression Analysis
1
2014
1547
0.020
Why?
Costs and Cost Analysis
1
2011
312
0.020
Why?
Magnetic Resonance Imaging
1
2007
7982
0.020
Why?
Treatment Outcome
4
2013
34335
0.020
Why?
Propensity Score
1
2013
794
0.020
Why?
Vinblastine
1
2010
460
0.020
Why?
Survival Rate
2
2013
12475
0.020
Why?
Carboplatin
1
2010
844
0.020
Why?
Particle Size
1
2007
194
0.020
Why?
Treatment Failure
1
2010
1430
0.020
Why?
Reoperation
1
2011
1455
0.020
Why?
CD5 Antigens
1
2007
122
0.020
Why?
Mediastinal Neoplasms
1
2010
426
0.020
Why?
Microscopy, Electron
1
2007
618
0.020
Why?
Length of Stay
1
2013
2048
0.020
Why?
Mastectomy
1
2011
1569
0.020
Why?
Body Mass Index
1
2011
2281
0.010
Why?
Paclitaxel
1
2010
2061
0.010
Why?
Cisplatin
1
2010
2465
0.010
Why?
Rats, Sprague-Dawley
1
2007
2126
0.010
Why?
Recurrence
1
2010
4889
0.010
Why?
Incidence
1
2011
5893
0.010
Why?
Cell Survival
1
2007
3064
0.010
Why?
Flow Cytometry
1
2007
3069
0.010
Why?
Combined Modality Therapy
1
2011
9020
0.010
Why?
Disease-Free Survival
1
2011
10092
0.010
Why?
Cohort Studies
1
2011
9466
0.010
Why?
Models, Biological
1
2007
3242
0.010
Why?
Rats
1
2007
6233
0.010
Why?
Cytokines
1
2007
2870
0.010
Why?
Prognosis
1
2011
22348
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
16327
0.000
Why?
Animals
1
2007
61175
0.000
Why?
MEDFORD-DAVIS's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (191)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_